Clinical trial
Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative…
NCT00458276 · Idorsia Pharmaceuticals Ltd., Industry · Terminated
Key facts
| NCT number | NCT00458276 |
|---|---|
| Title | Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery |
| Official title | Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Cardiac Surgery |
| Lead sponsor | Idorsia Pharmaceuticals Ltd., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Diseases, Hypertension, Pulmonary |
| Intervention type | Drug |
| Interventions | tezosentan, placebo |
| Enrollment | 274 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Apr 10, 2007 |
| Last update posted | Jul 9, 2018 |
| Countries | Austria, Canada, Czechia, France, Germany, India, Israel, Italy, Poland, Serbia, Slovakia, Sweden and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: